Statistics for Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

Total visits

views
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03) 3

Total visits per month

views
December 2024 0
January 2025 0
February 2025 1
March 2025 0
April 2025 0
May 2025 0
June 2025 0

File Visits

views
java.util.UUID:25b20e22-63b4-4980-9a46-57f64058d4c2 9

Top country views

views
United States 2
Antigua & Barbuda 1

Top city views

views
Greenwood 2
St John's 1